BENITEC BIOPHARMA LIMITED - Announcements

0.00%

2.6¢

Currently unlisted.

ASX:PAR

This stock could have something close to a cure for osteoarthritis. Paradigm Biopharmaceuticals (ASX:PAR) is a late-stage drug development company working first and foremost to create a superior treatment for osteoarthritis.

Announcements

Filter Results

All Price Sensitive Only

BLT	Appendix 4C - quarterly	PRICE SENSITIVE	28/07/10	144.16KB	Share
BLT	Continues to Expand Patent Portfolio in Gene Expression		14/07/10	28.91KB	Share
BLT	Securities Update and Appendix 3B		14/07/10	265.58KB	Share
BLT	Release of Securities from Voluntary Escrow		08/07/10	26.7KB	Share
BLT	Results of Meeting		30/06/10	227.31KB	Share
BLT	Benitec granted Hepatitis C RNA Interference Patent in US	PRICE SENSITIVE	18/06/10	28.54KB	Share
BLT	Benitec HIV/AIDS Stem Cell Clinical Trial results published	PRICE SENSITIVE	17/06/10	44.02KB	Share
BLT	Initial results from Lung Cancer Collaboration published		16/06/10	110.3KB	Share
BLT	CEO Principal Terms and Conditions of Employment		15/06/10	32.2KB	Share
BLT	Benitec appoints DR Peter French as CEO	PRICE SENSITIVE	15/06/10	31.96KB	Share
BLT	Appendix 3B		11/06/10	88.35KB	Share
BLT	Initial Director's Interest Notice		02/06/10	22.66KB	Share
BLT	Benitec US Patent Re-exam Update		02/06/10	27.5KB	Share
BLT	Benitec appoints Mr Iain Ross as Director		01/06/10	28.43KB	Share
BLT	Notice of General Meeting/Proxy Form		31/05/10	1.89MB	Share
BLT	Appendix 4C - quarterly	PRICE SENSITIVE	29/04/10	144.14KB	Share
BLT	Benitec T cell HIV Trial Open for Recruitment	PRICE SENSITIVE	12/04/10	30.91KB	Share
BLT	Benitec raises US$6 Million via Convertible Note	PRICE SENSITIVE	12/04/10	39.74KB	Share
BLT	Final Director's Interest Notice		31/03/10	23.88KB	Share
BLT	Benitec Board and Senior Management Update	PRICE SENSITIVE	29/03/10	32.62KB	Share
BLT	Benitec Graham Patent Granted in Japan	PRICE SENSITIVE	12/03/10	28.09KB	Share
BLT	Benitec US Patent Re-exam Update		09/03/10	27.42KB	Share
BLT	Change in substantial holding		05/03/10	28.97KB	Share
BLT	Company Contact Details		26/02/10	28.31KB	Share
BLT	Half Yearly Report and Accounts	PRICE SENSITIVE	25/02/10	1.79MB	Share
BLT	Appendix 3B Issue of Shares		25/02/10	88.61KB	Share
BLT	Benitec Licensee achieves Significant Milestone with Pfizer	PRICE SENSITIVE	05/02/10	37.46KB	Share
BLT	Initial Director's Interest Notice		03/02/10	22.88KB	Share
BLT	Benitec appoints Dr John Chiplin as Director		01/02/10	28.61KB	Share
BLT	Appendix 4C Quarterly Cash Flow Report	PRICE SENSITIVE	29/01/10	144.15KB	Share
BLT	Correction: US Graham Patent 10/646,070 Notice of Allowance		29/01/10	27.53KB	Share
BLT	US Graham Patent 90/007,247 Notice of Allowance		29/01/10	27.53KB	Share
BLT	Benitec US Re-exam Update	PRICE SENSITIVE	13/01/10	28.53KB	Share
BLT	Appendix 3B Issue of Shares		11/01/10	89.36KB	Share
BLT	Company Contact Details		11/01/10	28.31KB	Share
BLT	Trading Halt	PRICE SENSITIVE	11/01/10	82.77KB	Share
BLT	Benitec and CSIRO reach Win-Win Agreement	PRICE SENSITIVE	04/01/10	172.37KB	Share
BLT	CEO Presentation to Shareholders		18/11/09	613.4KB	Share
BLT	Results of Meeting		18/11/09	136.16KB	Share
BLT	Chairman's Address to AGM		18/11/09	70.61KB	Share
BLT	Appendix 4C Quarterly Cash Flow Report	PRICE SENSITIVE	30/10/09	144.13KB	Share
BLT	Options Update		23/10/09	25.71KB	Share
BLT	Additional Information for AGM		23/10/09	34.94KB	Share
BLT	Notice of Annual General Meeting/Proxy Form		19/10/09	2.17MB	Share
BLT	Annual Report to shareholders		16/10/09	645.96KB	Share
BLT	Notice of Annual General Meeting/Proxy Form		16/10/09	1.08MB	Share
BLT	Movements in Benitec Options		15/10/09	273.61KB	Share
BLT	Benitec secures Rights to T cell HIV Therapeutic	PRICE SENSITIVE	06/10/09	42.75KB	Share
BLT	Collaboration on RNAi Therapeutic for Lung Cancer	PRICE SENSITIVE	01/10/09	32.48KB	Share
BLT	Benitec Biomics Biotechnologies China Update		07/09/09	28.52KB	Share
BLT	Benitec Fully Owned Patent Granted in US	PRICE SENSITIVE	31/08/09	32.82KB	Share
BLT	Appendix 4E and Full Year Annual Report	PRICE SENSITIVE	28/08/09	529.55KB	Share
BLT	Appendix 3B correction		04/08/09	140.41KB	Share
BLT	Benitec appoints new Chief Scientific Officer		03/08/09	28.93KB	Share
BLT	Final Issue of Shortfall Shares and Options		31/07/09	35.23KB	Share
BLT	Appendix 3B Shortfall Allotment		31/07/09	89.34KB	Share
BLT	Cleansing Notice		31/07/09	29.74KB	Share
BLT	Appendix 4C Quarterly Cash Flow Report	PRICE SENSITIVE	30/07/09	144.59KB	Share
BLT	Benitec US Re-exam Update		28/07/09	28.03KB	Share
BLT	Benitec MOU with Biomics Biotechnologies China	PRICE SENSITIVE	14/07/09	63.67KB	Share
BLT	Further Issue of Shortfall Shares and Options		02/07/09	26.28KB	Share
BLT	Appendix 3B Shortfall Allotment		02/07/09	89.65KB	Share
BLT	Section 708A Notice		02/07/09	29.76KB	Share
BLT	Expiry of Unlisted Options		29/06/09	149.51KB	Share
BLT	Appendix 3B Shortfall Allotment		12/06/09	89.59KB	Share
BLT	Section 708A Notice		12/06/09	29.76KB	Share
BLT	Further Issue of Shortfall Shares and Options		12/06/09	26.26KB	Share
BLT	Section 708A Notice		27/05/09	29.74KB	Share
BLT	Further Issue of Shortfall Shares and Options		27/05/09	26.27KB	Share
BLT	Appendix 3B Shortfall Allotment		27/05/09	89.59KB	Share
BLT	Benitec US Re-exam Update		26/05/09	30.86KB	Share
BLT	Issue of Shortfall Shares and Options Update		18/05/09	28.16KB	Share
BLT	Appendix 3B		18/05/09	91.59KB	Share
BLT	Section 708A Notice		18/05/09	29.73KB	Share
BLT	Change in substantial holding		12/05/09	54.22KB	Share
BLT	Appendix 3B Completion of Rights Issue		07/05/09	91.59KB	Share
BLT	Completion of Rights Issue		07/05/09	53.82KB	Share
BLT	Benitec and City of Hope Human Trial Update		06/05/09	32.34KB	Share
BLT	Benitec US Re-exam Update	PRICE SENSITIVE	05/05/09	28.3KB	Share
BLT	Rights Issue - Notification of Shortfall		05/05/09	30.8KB	Share
BLT	Appendix 4C Quarterly Cash Flow Report	PRICE SENSITIVE	30/04/09	144.18KB	Share
BLT	Closing of Non Renounceable Rights Issue		30/04/09	27.52KB	Share
BLT	Final Director's Interest Notice		24/04/09	24.17KB	Share
BLT	Director Resignation		17/04/09	27.8KB	Share
BLT	Appendix 3B Rights Issue - Correction		08/04/09	278.26KB	Share
BLT	Company Contact Details		06/04/09	27.37KB	Share
BLT	Letter to Option Holders		01/04/09	44.13KB	Share
BLT	Non Renounceable Rights Issue Appendix 3B		01/04/09	90.49KB	Share
BLT	Non Renounceable Rights Issue - Prospectus	PRICE SENSITIVE	01/04/09	174.8KB	Share
BLT	Benitec US Re-exam Update		26/03/09	31.41KB	Share
BLT	Movements in Benitec Shares and Options		24/03/09	272.46KB	Share
BLT	Benitec withdraws from renegotiations with CSIRO	PRICE SENSITIVE	12/03/09	29.78KB	Share
BLT	Half Yearly Report and Accounts	PRICE SENSITIVE	27/02/09	1.47MB	Share
BLT	Change in substantial holding		10/02/09	56.21KB	Share
BLT	City of Hope Human Trial Update	PRICE SENSITIVE	09/02/09	348.18KB	Share
BLT	Benitec confirms Capital Raising		09/02/09	79.24KB	Share
BLT	Appendix 4C - quarterly	PRICE SENSITIVE	30/01/09	144.44KB	Share
BLT	Results of Meeting		07/01/09	134.44KB	Share
BLT	Notice of General Meeting/Proxy Form		08/12/08	922.04KB	Share
BLT	Benitec City of Hope Human Trial Update	PRICE SENSITIVE	08/12/08	172.84KB	Share

BLTAppendix 4C - quarterly
28/07/10	PRICE SENSITIVE	144.16KB	Share
BLTContinues to Expand Patent Portfolio in Gene Expression
14/07/10		28.91KB	Share
BLTSecurities Update and Appendix 3B
14/07/10		265.58KB	Share
BLTRelease of Securities from Voluntary Escrow
08/07/10		26.7KB	Share
BLTResults of Meeting
30/06/10		227.31KB	Share
BLTBenitec granted Hepatitis C RNA Interference Patent in US
18/06/10	PRICE SENSITIVE	28.54KB	Share
BLTBenitec HIV/AIDS Stem Cell Clinical Trial results published
17/06/10	PRICE SENSITIVE	44.02KB	Share
BLTInitial results from Lung Cancer Collaboration published
16/06/10		110.3KB	Share
BLTCEO Principal Terms and Conditions of Employment
15/06/10		32.2KB	Share
BLTBenitec appoints DR Peter French as CEO
15/06/10	PRICE SENSITIVE	31.96KB	Share
BLTAppendix 3B
11/06/10		88.35KB	Share
BLTInitial Director's Interest Notice
02/06/10		22.66KB	Share
BLTBenitec US Patent Re-exam Update
02/06/10		27.5KB	Share
BLTBenitec appoints Mr Iain Ross as Director
01/06/10		28.43KB	Share
BLTNotice of General Meeting/Proxy Form
31/05/10		1.89MB	Share
BLTAppendix 4C - quarterly
29/04/10	PRICE SENSITIVE	144.14KB	Share
BLTBenitec T cell HIV Trial Open for Recruitment
12/04/10	PRICE SENSITIVE	30.91KB	Share
BLTBenitec raises US$6 Million via Convertible Note
12/04/10	PRICE SENSITIVE	39.74KB	Share
BLTFinal Director's Interest Notice
31/03/10		23.88KB	Share
BLTBenitec Board and Senior Management Update
29/03/10	PRICE SENSITIVE	32.62KB	Share
BLTBenitec Graham Patent Granted in Japan
12/03/10	PRICE SENSITIVE	28.09KB	Share
BLTBenitec US Patent Re-exam Update
09/03/10		27.42KB	Share
BLTChange in substantial holding
05/03/10		28.97KB	Share
BLTCompany Contact Details
26/02/10		28.31KB	Share
BLTHalf Yearly Report and Accounts
25/02/10	PRICE SENSITIVE	1.79MB	Share
BLTAppendix 3B Issue of Shares
25/02/10		88.61KB	Share
BLTBenitec Licensee achieves Significant Milestone with Pfizer
05/02/10	PRICE SENSITIVE	37.46KB	Share
BLTInitial Director's Interest Notice
03/02/10		22.88KB	Share
BLTBenitec appoints Dr John Chiplin as Director
01/02/10		28.61KB	Share
BLTAppendix 4C Quarterly Cash Flow Report
29/01/10	PRICE SENSITIVE	144.15KB	Share
BLTCorrection: US Graham Patent 10/646,070 Notice of Allowance
29/01/10		27.53KB	Share
BLTUS Graham Patent 90/007,247 Notice of Allowance
29/01/10		27.53KB	Share
BLTBenitec US Re-exam Update
13/01/10	PRICE SENSITIVE	28.53KB	Share
BLTAppendix 3B Issue of Shares
11/01/10		89.36KB	Share
BLTCompany Contact Details
11/01/10		28.31KB	Share
BLTTrading Halt
11/01/10	PRICE SENSITIVE	82.77KB	Share
BLTBenitec and CSIRO reach Win-Win Agreement
04/01/10	PRICE SENSITIVE	172.37KB	Share
BLTCEO Presentation to Shareholders
18/11/09		613.4KB	Share
BLTResults of Meeting
18/11/09		136.16KB	Share
BLTChairman's Address to AGM
18/11/09		70.61KB	Share
BLTAppendix 4C Quarterly Cash Flow Report
30/10/09	PRICE SENSITIVE	144.13KB	Share
BLTOptions Update
23/10/09		25.71KB	Share
BLTAdditional Information for AGM
23/10/09		34.94KB	Share
BLTNotice of Annual General Meeting/Proxy Form
19/10/09		2.17MB	Share
BLTAnnual Report to shareholders
16/10/09		645.96KB	Share
BLTNotice of Annual General Meeting/Proxy Form
16/10/09		1.08MB	Share
BLTMovements in Benitec Options
15/10/09		273.61KB	Share
BLTBenitec secures Rights to T cell HIV Therapeutic
06/10/09	PRICE SENSITIVE	42.75KB	Share
BLTCollaboration on RNAi Therapeutic for Lung Cancer
01/10/09	PRICE SENSITIVE	32.48KB	Share
BLTBenitec Biomics Biotechnologies China Update
07/09/09		28.52KB	Share
BLTBenitec Fully Owned Patent Granted in US
31/08/09	PRICE SENSITIVE	32.82KB	Share
BLTAppendix 4E and Full Year Annual Report
28/08/09	PRICE SENSITIVE	529.55KB	Share
BLTAppendix 3B correction
04/08/09		140.41KB	Share
BLTBenitec appoints new Chief Scientific Officer
03/08/09		28.93KB	Share
BLTFinal Issue of Shortfall Shares and Options
31/07/09		35.23KB	Share
BLTAppendix 3B Shortfall Allotment
31/07/09		89.34KB	Share
BLTCleansing Notice
31/07/09		29.74KB	Share
BLTAppendix 4C Quarterly Cash Flow Report
30/07/09	PRICE SENSITIVE	144.59KB	Share
BLTBenitec US Re-exam Update
28/07/09		28.03KB	Share
BLTBenitec MOU with Biomics Biotechnologies China
14/07/09	PRICE SENSITIVE	63.67KB	Share
BLTFurther Issue of Shortfall Shares and Options
02/07/09		26.28KB	Share
BLTAppendix 3B Shortfall Allotment
02/07/09		89.65KB	Share
BLTSection 708A Notice
02/07/09		29.76KB	Share
BLTExpiry of Unlisted Options
29/06/09		149.51KB	Share
BLTAppendix 3B Shortfall Allotment
12/06/09		89.59KB	Share
BLTSection 708A Notice
12/06/09		29.76KB	Share
BLTFurther Issue of Shortfall Shares and Options
12/06/09		26.26KB	Share
BLTSection 708A Notice
27/05/09		29.74KB	Share
BLTFurther Issue of Shortfall Shares and Options
27/05/09		26.27KB	Share
BLTAppendix 3B Shortfall Allotment
27/05/09		89.59KB	Share
BLTBenitec US Re-exam Update
26/05/09		30.86KB	Share
BLTIssue of Shortfall Shares and Options Update
18/05/09		28.16KB	Share
BLTAppendix 3B
18/05/09		91.59KB	Share
BLTSection 708A Notice
18/05/09		29.73KB	Share
BLTChange in substantial holding
12/05/09		54.22KB	Share
BLTAppendix 3B Completion of Rights Issue
07/05/09		91.59KB	Share
BLTCompletion of Rights Issue
07/05/09		53.82KB	Share
BLTBenitec and City of Hope Human Trial Update
06/05/09		32.34KB	Share
BLTBenitec US Re-exam Update
05/05/09	PRICE SENSITIVE	28.3KB	Share
BLTRights Issue - Notification of Shortfall
05/05/09		30.8KB	Share
BLTAppendix 4C Quarterly Cash Flow Report
30/04/09	PRICE SENSITIVE	144.18KB	Share
BLTClosing of Non Renounceable Rights Issue
30/04/09		27.52KB	Share
BLTFinal Director's Interest Notice
24/04/09		24.17KB	Share
BLTDirector Resignation
17/04/09		27.8KB	Share
BLTAppendix 3B Rights Issue - Correction
08/04/09		278.26KB	Share
BLTCompany Contact Details
06/04/09		27.37KB	Share
BLTLetter to Option Holders
01/04/09		44.13KB	Share
BLTNon Renounceable Rights Issue Appendix 3B
01/04/09		90.49KB	Share
BLTNon Renounceable Rights Issue - Prospectus
01/04/09	PRICE SENSITIVE	174.8KB	Share
BLTBenitec US Re-exam Update
26/03/09		31.41KB	Share
BLTMovements in Benitec Shares and Options
24/03/09		272.46KB	Share
BLTBenitec withdraws from renegotiations with CSIRO
12/03/09	PRICE SENSITIVE	29.78KB	Share
BLTHalf Yearly Report and Accounts
27/02/09	PRICE SENSITIVE	1.47MB	Share
BLTChange in substantial holding
10/02/09		56.21KB	Share
BLTCity of Hope Human Trial Update
09/02/09	PRICE SENSITIVE	348.18KB	Share
BLTBenitec confirms Capital Raising
09/02/09		79.24KB	Share
BLTAppendix 4C - quarterly
30/01/09	PRICE SENSITIVE	144.44KB	Share
BLTResults of Meeting
07/01/09		134.44KB	Share
BLTNotice of General Meeting/Proxy Form
08/12/08		922.04KB	Share
BLTBenitec City of Hope Human Trial Update
08/12/08	PRICE SENSITIVE	172.84KB	Share

REFRESH

First 4 5 6 7 8

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

BENITEC BIOPHARMA LIMITED - Announcements

Announcements

Top Stories